Doctors have reported the results of a novel targeted therapy that may represent a new treatment option for individuals with Crohn’s disease. Risankizumab is a [...]
Crohn’s disease is an idiopathic, chronic, inflammatory process that can affect any part of the gastrointestinal (GI) tract from the mouth to the anus. Individuals [...]
Almost 700,000 people in the U.S. suffer from Crohn’s disease however each individuals experience with the chronic illness is unique and can differ significantly from others. For [...]
Managing a chronic disease, such as Crohn’s disease or ulcerative colitis is difficult enough to begin with and can be made much more difficult if [...]
 |
 |
 |
